Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AG-920 (CYKLX) vs Proparacaine for Ocular Anesthesia in Pediatrics
NCT05325853Phase 3Completed
- Sponsor
- American Genomics
- Start
- Apr 2022
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of articaine in ocular anesthesia (2 arms), sponsored by American Genomics. Primary endpoint: Proportion of Participants in Which an Eye Exam Was Able to be Performed. Started Apr 2022; status: completed.
02
Drugs
articaine
03
Conditions
ocular anesthesia
Beyond the preview
Go deeper on NCT05325853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05325853.